Tag: Spdr S&P Pharmaceuticals Etf

Eli Lilly says next-generation weight loss drug clears crucial obesity trial

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly